Search results
Results from the WOW.Com Content Network
Hyperthermia therapy (or hyperthermia, or thermotherapy) is a type of medical treatment in which body tissue is exposed to temperatures above body temperature, in the region of 40–45 °C (104–113 °F). Hyperthermia is usually applied as an adjuvant to radiotherapy or chemotherapy, to which it works as a sensitizer, in an effort to treat cancer.
Targeted temperature management (TTM), previously known as therapeutic hypothermia or protective hypothermia, is an active treatment that tries to achieve and maintain a specific body temperature in a person for a specific duration of time in an effort to improve health outcomes during recovery after a period of stopped blood flow to the brain. [1]
Hyperthermia is generally diagnosed by the combination of unexpectedly high body temperature and a history that supports hyperthermia instead of a fever. [2] Most commonly this means that the elevated temperature has occurred in a hot, humid environment (heat stroke) or in someone taking a drug for which hyperthermia is a known side effect ...
[13] [15] It differs from hyperthermia, in that hyperthermia is an increase in body temperature over the temperature set point, due to either too much heat production or not enough heat loss. [1] Treatment to reduce fever is generally not required. [2] [9] Treatment of associated pain and inflammation, however, may be useful and help a person ...
Dantrolene, a muscle relaxant used to treat other forms of hyperthermia, is not an effective treatment for heat stroke. [25] Antipyretics such as aspirin and acetaminophen are also not recommended as a means to lower body temperature in the treatment of heat stroke and their use may lead to worsening liver damage. [5]
Readiness for enhanced therapeutic regimen management is a NANDA approved nursing diagnosis which is defined as "A pattern of regulating and integrating into daily living a program(s) for treatment of illness and its sequelae that is sufficient for meeting health-related goals and can be strengthened."
Shortwave diathermy can also be used for hyperthermia therapy and electrolysis therapy, as an adjuvant to radiation in cancer treatment, especially 8.00 MHz. Typically, hyperthermia would be added twice a week before radiation therapy, as shown in the photograph from a 2010 clinical trial at the Mahavir Cancer Sansthan in Patna, India.
It covers research and clinical studies and trials on hyperthermia and other thermal therapies (e.g. thermal ablation, cryo therapies) which fall largely into the three main categories of clinical studies, biological studies, and physics/engineering studies on techniques of heat delivery and temperature measurement. [1]